spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Sirna Therapeutics 

 HSMN NewsFeed - 1 Jul 2021
Sirnaomics Secures $105 Million in Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Nov 2015
Calimmune Expands Board of Directors, Names R. Scott Greer as Chairman
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Oct 2013
Auspex Appoints Pratik Shah as CEO and Expands Executive Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Oct 2013
Gregory L. Weaver Joins Atossa Genetics' Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 19 Dec 2012
Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jun 2012
Alnylam Expands and Develops Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2010
Dicerna Pharmaceuticals Announces Second Close of Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Aug 2010
Dicerna Closes $25 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 6 May 2010
Dicerna Names Douglas Fambrough as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2010
Intuity Medical Closes $64 Million Series D Financing - One of the Largest Medical Device Funding Events of 2009
Devices Monitoring Endocrinology Venture Capital
 HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 19 Feb 2009
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Nov 2008
Awarepoint Corporation Closes $13.3 M Series D Financing Round
Devices Venture Capital
 HSMN NewsFeed - 10 Jun 2008
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2008
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Oct 2007
New Leaf Venture Partners Closes $450 Million Healthcare Fund
Venture Capital
 HSMN NewsFeed - 8 Oct 2007
Anaptys Biosciences Appoints R. Scott Greer to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2007
Oxford Bioscience Partners Promotes Dr. Douglas Fambrough to General Partner
Venture Capital Personnel
 HSMN NewsFeed - 9 Apr 2007
Innovative Pulmonary and PEGylation-Based Therapeutic Product Development Drives Business Strategy of Nektar Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2007
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
Nektar Appoints Howard W. Robin President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2006
Merck & Co., Inc. Announces Completion of Acquisition of Sirna Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Dec 2006
Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Dec 2006
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Dec 2006
Merck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of Sirna by Merck
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals
 HSMN NewsFeed - 30 Oct 2006
Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2006
Protiva Files Suit Against Inex in California Superior Court
Biopharmaceuticals Litigation
 HSMN NewsFeed - 21 Aug 2006
Alnylam Grants Calando a License to Develop and Commercialize an RNAi Therapeutic Product
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Aug 2006
Calando Pharmaceuticals Appoints Jeremy D. Heidel as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2006
Sirna Therapeutics Announces Programs in Strategic Research Alliance With GlaxoSmithKline
Biopharmaceuticals
 HSMN NewsFeed - 3 Apr 2006
GlaxoSmithKline and Sirna Therapeutics Announce Major Alliance in RNAi-Based Therapeutics for Respiratory Disease
Biopharmaceuticals
 HSMN NewsFeed - 22 Feb 2006
Catalyst Announces Appointment of Nassim Usman as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2006
Sirna Therapeutics Appoints Gregory Weaver as Chief Financial Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 23 additional stories matching:
Sirna Therapeutics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.